APA

Potamianou A., Ziras N., Bountouroglou N., Varthalitis J., Karvounis N., Pectasidis D. & Athanassiou A. E. (20121002). Methotrexate, etoposide, ifosfamide and cisplatin (MVIP): An effective salvage therapy for patients with refractory or relapsed germ-cell tumors. : Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Chicago

Potamianou A, Ziras N, Bountouroglou N, Varthalitis J, Karvounis N, Pectasidis D and Athanassiou A E. 20121002. Methotrexate, etoposide, ifosfamide and cisplatin (MVIP): An effective salvage therapy for patients with refractory or relapsed germ-cell tumors. : Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Harvard

Potamianou A., Ziras N., Bountouroglou N., Varthalitis J., Karvounis N., Pectasidis D. and Athanassiou A. E. (20121002). Methotrexate, etoposide, ifosfamide and cisplatin (MVIP): An effective salvage therapy for patients with refractory or relapsed germ-cell tumors. : Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

MLA

Potamianou A, Ziras N, Bountouroglou N, Varthalitis J, Karvounis N, Pectasidis D and Athanassiou A E. Methotrexate, etoposide, ifosfamide and cisplatin (MVIP): An effective salvage therapy for patients with refractory or relapsed germ-cell tumors. : Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20121002.